Literature DB >> 16412149

Serotonin depletion, cortical spreading depression, and trigeminal nociception.

Weera Supornsilpchai1, Sompol Sanguanrangsirikul, Supang Maneesri, Anan Srikiatkhachorn.   

Abstract

BACKGROUND: The attack of migraine has been observed to be associated with low level of serotonin (5-HT). Although the mechanism underlying this relationship is still unclear, change in cortical excitability or susceptibility of trigeminal system is a possible explanation.
OBJECTIVES: The aim was to study the effect of 5-HT depletion on the development of cortical spreading depression (CSD) and CSD-evoked trigeminal nociception.
METHODS: Wistar rats were separated into low 5-HT and control groups (eight rats each). 5-HT was depleted by administration of para-chlorophenylalanine, a tryptophan hydroxylase inhibitor. CSD was induced by applying 3 mg of potassium chloride on parietal cortex. Cortical activity was monitored for 1 hour. Trigeminal nociception was determined using number of Fos-immunoreactive (Fos-IR) neurons in trigeminal nucleus caudalis as the indicator.
RESULTS: Application of KCl led to the development of series of depolarization shift characteristics for CSD. The development of these CSD waves was enhanced in low 5-HT state. The area under curve of each CSD wave and the number of CSD waves occurring within 1 hour were greater in low 5-HT group. No significant change in peak amplitude and duration of CSD wave was observed. The numbers of Fos-IR cells on ipsilateral and contralateral trigeminal nucleus caudalis were significantly greater in the low 5-HT group than those of the controls.
CONCLUSION: Our findings indicate that 5-HT depletion enhances CSD-induced trigeminal nociception by increasing the cortical excitability and sensitivity of trigeminal nociceptive system. These findings may provide a better understanding regarding the relationship between low 5-HT and clinical headaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412149     DOI: 10.1111/j.1526-4610.2006.00310.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  26 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  Serotonergic agents in the management of cluster headache.

Authors:  Giorgio Lambru; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2011-04

Review 3.  Pathophysiology of medication-overuse headache: implications from animal studies.

Authors:  Saknan Bongsebandhu-phubhakdi; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 4.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

5.  Associations between migraine attacks and nightly sleep characteristics among adults with episodic migraine: a prospective cohort study.

Authors:  Angeliki Vgontzas; Wenyuan Li; Elizabeth Mostofsky; Michael Rueschman; Murray A Mittleman; Suzanne M Bertisch
Journal:  Sleep       Date:  2020-07-13       Impact factor: 5.849

Review 6.  Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction.

Authors:  Juan Piantino; Miranda M Lim; Craig D Newgard; Jeffrey Iliff
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

7.  Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

Authors:  Matthew W Johnson; R Andrew Sewell; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-11-29       Impact factor: 4.492

8.  [Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; C Göbel; A Göbel; A Heinze
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

Review 9.  Migraine is a neuronal disease.

Authors:  J Tajti; A Párdutz; E Vámos; B Tuka; A Kuris; Zs Bohár; A Fejes; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2010-12-15       Impact factor: 3.575

10.  Genetic TPH2 variants and the susceptibility for migraine: association of a TPH2 haplotype with migraine without aura.

Authors:  Alexander Jung; Andreas Huge; Gregor Kuhlenbäumer; Steffi Kempt; Tanja Seehafer; Stefan Evers; Klaus Berger; Martin Marziniak
Journal:  J Neural Transm (Vienna)       Date:  2010-08-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.